Introduction {#sec1}
============

Diffusive clearance depends on blood flow rate, dialysate flow rate and the product of the overall mass transfer coefficient and membrane surface area (*K*~o~*A*). *K*~o~ is a measure of the overall resistance to mass transfer for a given solute and incorporates the resistances associated with diffusion of the solute to the membrane surface on the blood side, diffusion through the membrane and diffusion across the slow-moving boundary layer on the dialysate side of the membrane \[[@ref1]\]. *K*~o~*A* is usually assumed constant for a given dialyzer--solute combination. However, Leypoldt *et al*. showed that increasing dialysate flow rate from 500 to 800 mL/min in a variety of dialyzers increased urea *K*~o~*A* by 14% *in vitro* \[[@ref2]\]. They suggested this increase could result from improved flow distribution through the dialysate compartment or decreased dialysate boundary layer resistance to mass transfer. Subsequently, we showed urea *K*~o~*A* also depends on dialysate flow rate during clinical dialysis \[[@ref3]\], and Hauk *et al.* found a greater than predicted increase in urea Kt/*V* when dialysate flow rate was increased from 500 to 800 mL/min \[[@ref4]\]. Newer dialyzers incorporate features, such as hollow fiber undulations and spacer yarns, that improve flow distribution through the dialysate compartment \[[@ref5]\]. However, even in these dialyzers, urea *K*~o~*A* has been reported to increase with increasing dialysate flow rate *in vitro* \[[@ref6]\]. These observations suggest that the boundary layer and maldistribution of the dialysate flow remain important factors limiting the efficiency of urea removal by dialysis.

In addition to dialysate flow rate, dialysate distribution and boundary layer thickness might also be affected by the packing density of hollow fibers in the dialyzer. A low packing density might allow channeling of dialysate through the fiber bundle, leading to areas of semi-stagnant flow, while a high packing density might impede free flow of dialysate through the fiber bundle. To determine the impact of these factors on dialyzer performance during clinical dialysis, we examined the dependence of *K*~o~*A* on dialysate flow rate for two different membrane packing densities using three different test solutes, urea, phosphate and β~2~-microglobulin.

Materials and methods {#sec2}
=====================

Study design {#sec3}
------------

Solute transport was evaluated in a cross-over study with four different dialyzers containing undulating fibers, Revaclear and Revaclear MAX (Gambro Renal Products, Lakewood, CO) and Optiflux F160NR and Optiflux F200NR (Fresenius Medical Care, Lexington, MA) ([Table 1](#tab1){ref-type="table"}). The dialyzers were used in random order, each for three consecutive treatments, and were not reused. Treatments were performed using Phoenix dialysis machines (Gambro).

###### 

Dialyzers

  Dialyzer          Membrane[^a^](#tfn1){ref-type="table-fn"}   Shell diameter (mm)   Number of fibers   Fiber length (mm)   Fiber inner diameter (μm)[^b^](#tfn2){ref-type="table-fn"}   Membrane area (m^2^)[^c^](#tfn3){ref-type="table-fn"}   Membrane wall thickness (μm)[^b^](#tfn2){ref-type="table-fn"}   Fiber packing density (%)[^d^](#tfn4){ref-type="table-fn"}   Sterilization
  ----------------- ------------------------------------------- --------------------- ------------------ ------------------- ------------------------------------------------------------ ------------------------------------------------------- --------------------------------------------------------------- ------------------------------------------------------------ ---------------
  Optiflux F160NR   PS/PVP                                      40.4                  10 700             232.5               200                                                          1.56                                                    40                                                              51                                                           Electron beam
  Optiflux F200NR   PS/PVP                                      48                    13 400             232.5               200                                                          1.96                                                    40                                                              46                                                           Electron beam
  Revaclear         PAES/PVP                                    34                    9600               236.3               190                                                          1.36                                                    35                                                              56                                                           Steam
  Revaclear MAX     PAES/PVP                                    38                    12 000             236.3               190                                                          1.70                                                    35                                                              56                                                           Steam

PS = polysulfone; PVP = polyvinylpyrrolidone; PAES = polyarylethersulfone.

Manufacturer's data.

Calculated from the number of fibers and fiber dimensions.

Calculated as the ratio of membrane cross-sectional area to the internal cross-sectional area of the dialyzer housing expressed as a percentage. The cross-sectional area of membrane was calculated from the number of fibers and the manufacturer's data for fiber diameter and wall thickness.

Dialyzer performance was determined during the third treatment with each dialyzer. Clearances of urea, phosphate and β~2~-microglobulin were determined during the first 45 min of dialysis at the minimum ultrafiltration rate allowed by the dialysis machine (100 mL/h), a blood flow rate of 400 mL/min and dialysate flow rates of 350, 500 and 800 mL/min, used in random order.

The study was registered with ClinicalTrials.gov (identifier NCT00636077).

Subjects {#sec4}
--------

Subjects were enrolled from patients receiving dialysis through the University of Louisville Kidney Disease Program. For inclusion in the study, subjects were required to be older than 18 years, have a stable haemodialysis prescription, a native fistula or Gore-Tex graft capable of providing a blood flow of 400 mL/min and an expected fluid removal of no more than 3 L per treatment. Exclusion criteria included non-compliance with the dialysis prescription, a haematocrit \<28% or an active infection. The Human Studies Committee of the University of Louisville reviewed the protocol and all subjects provided informed consent before participating in the study.

Measurement of clearance {#sec5}
------------------------

Clearances of urea, phosphate and β~2~-microglobulin were determined using standard methods. Briefly, blood and dialysate flow rates were set at the desired values, and the net ultrafiltration rate was set to minimum, using the dialysis machine displays. After 15 min, blood samples were drawn from the inlet and outlet blood lines of the dialyzer, and a dialysate sample was obtained from the outlet dialysate line. Plasma was obtained by centrifugation. Before plasma separation, a well-mixed aliquot was taken from the inlet blood sample to determine haematocrit.

Analytical methods {#sec6}
------------------

Urea concentrations were determined by routine clinical laboratory methods. Phosphate concentrations were measured by the method of Chen *et al.* \[[@ref7]\] adapted for a microplate spectrophotometer (SPECTRAmax Plus, Molecular Devices, Sunnyvale, CA). β~2~-Microglobulin concentrations were measured by an immunometric assay (Immulite, Diagnostic Products Corporation, Los Angeles, CA).

Data analysis {#sec7}
-------------

Instantaneous solute clearances (*K*) were calculated from arterial (*C*~Pi~) and venous (*C*~Po~) plasma concentrations and the outlet dialysate concentration (*C*~Do~) \[[@ref8]\]: $$K = Q_{\text{Beffi}}\frac{\left( {C_{\text{Pi}} - C_{\text{Po}}} \right)}{C_{\text{Pi}}} + Q_{\text{UF}}\frac{C_{\text{Po}}}{C_{\text{Pi}}} = \left( {Q_{\text{D}} + Q_{\text{UF}}} \right)\frac{C_{\text{Do}}}{C_{\text{Pi}}}$$Where *Q*~Beffi~ is the effective blood-side flow rate for a given solute at the inlet to the dialyzer and *Q*~UF~ is the instantaneous ultrafiltration rate. For urea, *Q*~Beffi~ was assumed to be the blood water flow rate at the inlet to the dialyzer (*Q*~BWi~), whereas for phosphate and β~2~-microglobulin *Q*~Beffi~ was assumed to be the plasma water flow rate at the inlet to the dialyzer (*Q*~PWi~) \[[@ref9]\]. These flow rates were calculated from: $$\begin{array}{l}
{Q_{\text{BWi}} = (0.93 \times \left( {1–\text{Hct}} \right)\  + \ 0.72 \times \text{Hct}) \times Q_{\text{Bi}}} \\
{Q_{\text{PWi}} = 0.93 \times \left( {1–\text{Hct}} \right) \times Q_{\text{Bi}}} \\
\end{array}$$Where *Q*~Bi~ is the blood flow rate at the inlet to the dialyzer, Hct is the fractional haematocrit and the constants 0.93 and 0.72 correct for the protein content of plasma and the non-water fraction of red blood cells, respectively \[[@ref9]\].

The product of overall mass transfer coefficient and membrane area (*K*~o~*A*) was calculated according to Michaels \[[@ref8]\]: $$K_{\text{o}}A = \frac{Q_{\text{Beffi}} \times Q_{\text{D}}}{Q_{\text{D}} - Q_{\text{Beffi}}} \times \ln\left\lbrack \frac{1 - K/Q_{\text{D}}}{1 - K/Q_{\text{Beffi}}} \right\rbrack$$

The overall mass transfer coefficient (*K*~o~) was calculated by dividing *K*~o~*A* by the membrane surface area of the dialyzer determined from the fiber numbers and dimensions listed in [Table 1](#tab1){ref-type="table"}.

The instantaneous rate of trapping β~2~-microglobulin at the dialyzer membrane was calculated as the difference between the amount of solute lost from the plasma water and the amount recovered in the effluent dialysate: $$M_{\text{trap}} = Q_{\text{PWi}} \times (C_{\text{Pi}} - C_{\text{Po}}) + Q_{\text{UF}}C_{\text{Po}}–Q_{\text{D}} \times C_{\text{DO}}$$

Data are presented as mean ± SEM. The statistical significance of differences among dialyzers and among dialysate flow rates was examined by analysis of variance. Where a significant difference was found by analysis of variance, the significance of differences between individual dialyzers or dialysate flow rates was assessed using a Bonferroni *post* *hoc* test. P-values \<0.05 were considered significant.

Results {#sec8}
=======

Patients {#sec9}
--------

Nine women and three men with an average age of 60 ± 4 years were enrolled in the study. They had been receiving haemodialysis for 81 ± 19 months. Their renal failure was caused by hypertension (five patients), glomerulonephritis (three patients), diabetes (one patient), systemic lupus erythematosus (one patient), polycystic kidney disease (one patient) and renal carcinoma (one patient). Blood access was via a fistula in three patients and a Gore-Tex graft in nine patients.

Dialysis treatments {#sec10}
-------------------

Anticoagulation, obtained using a loading dose (mean 1825 IU, range 1000--2500 IU) and constant infusion (mean 1192 IU/h, range 500--2000 IU/h) of unfractionated heparin, did not differ among dialyzers. Actual blood flow rates averaged 400 ± 2 mL/min and did not differ among dialyzers or dialysate flow rates.

Urea {#sec11}
----

Because urea moves rapidly across red cell membranes, urea clearances ([Table 2](#tab2){ref-type="table"}) were based on blood water flow rates. The quality of the clearance data was assessed by calculating the mass balance error for each determination of urea clearance. Overall, the mean absolute mass balance error was 5.2 ± 0.4%. Urea clearances for the Revaclear MAX were significantly higher than those for the Revaclear and the Optiflux F160NR (P \< 0.001), while clearances for the Optiflux F200NR were intermediate and not different from those of the other three dialyzers. Urea clearances increased significantly with increasing dialysate flow rate (P \< 0.001) and this increase was independent of the dialyzer.

###### 

Urea

  Dialyzer          Dialysate flow rate (mL/min)   Clearance (mL/min)^a^   *K*~o~*A* (mL/min)[^b^](#tfn6){ref-type="table-fn"}   *K*~o~ (cm/min)[^b^](#tfn6){ref-type="table-fn"}
  ----------------- ------------------------------ ----------------------- ----------------------------------------------------- --------------------------------------------------
  Optiflux F160NR   350                            232 ± 3                 720 ± 32                                              0.046 ± 0.002
  500               252 ± 7                        703 ± 38                0.045 ± 0.002                                         
  800               281 ± 3                        776 ± 23                0.050 ± 0.001                                         
  Optiflux F200NR   350                            237 ± 2                 749 ± 20                                              0.038 ± 0.001
  500               270 ± 4                        847 ± 33                0.043 ± 0.002                                         
  800               282 ± 5                        785 ± 35                0.040 ± 0.002                                         
  Revaclear         350                            233 ± 4                 718 ± 31                                              0.053 ± 0.002
  500               255 ± 5                        713 ± 33                0.052 ± 0.002                                         
  800               276 ± 3                        732 ± 24                0.054 ± 0.002                                         
  Revaclear MAX     350                            240 ± 3                 789 ± 29                                              0.046 ± 0.002
  500               270 ± 3                        852 ± 30                0.050 ± 0.002                                         
  800               293 ± 3                        884 ± 30                0.052 ± 0.002                                         

Clearances based on rate of disappearance from blood.

Calculated using the blood water flow rate (*Q*~BWi~).

Data are presented as mean ± SEM for *n* = 12 observations. Statistical differences are described in the text.

Because clearance is a function of blood and dialysate flow rates, the ability of a dialyzer to remove urea is often expressed in terms of *K*~o~*A*. Urea *K*~o~*A* and *K*~o~ values are presented in [Table 2](#tab2){ref-type="table"}. Differences in urea *K*~o~*A* among dialyzers were similar to those found for urea clearances, with the Revaclear MAX having a significantly higher *K*~o~*A* than the Revaclear and the Optiflux F160NR (P \< 0.001), and the Optiflux F200NR having a significantly higher *K*~o~*A* than the Revaclear (P = 0.025), but not the Optiflux F160NR. Urea *K*~o~*A* did not differ significantly among the three dialysate flow rates. After correcting for membrane surface area, the smaller surface area dialyzers tended to have higher urea *K*~o~ values than the larger surface area dialyzers. Urea *K*~o~ values for the Revaclear and the Optiflux F160NR were significantly higher than those for the Optiflux F200NR (P \< 0.001), but not the Revaclear MAX. Urea *K*~o~ did not differ significantly among the three dialysate flow rates. The boundary layer on the dialysate side of the membrane is one component of the resistance to mass transfer incorporated in *K*~o~ \[[@ref1]\]. The thickness of this boundary layer might be determined, in part, by the flow velocity in the dialysate compartment, which in turn is a function of the dialysate flow rate and the available cross-sectional area for flow. A higher membrane packing density results in a lower cross-sectional area for flow and a higher flow velocity. Therefore, we examined the relationship between urea *K*~o~ and the average dialysate velocity. The data in [Figure 1](#fig1){ref-type="fig"}A show that urea *K*~o~ increased significantly with increasing dialysate velocity (*r*^2^ = 0.228, P \< 0.001).

![Urea (panel **A**) and phosphate (panel **B**) *K*~o~ as a function of average dialysate velocity. Average dialysate velocity was calculated by dividing the dialysate flow rate by the free cross-sectional area of the dialysate compartment (cross-sectional area of the dialyzer housing − cross-sectional area of fibers).](gfq326fig1){#fig1}

Phosphate {#sec12}
---------

Unlike urea, transfer of phosphate out of red blood cells is sufficiently slow that plasma water and red blood cell water are not in equilibrium leaving the dialyzer. For that reason, phosphate clearances calculated using blood-side flow rates do not accurately reflect dialyzer performance. To avoid this problem, phosphate clearances ([Table 3](#tab3){ref-type="table"}) were calculated from the dialysate flow rate and outlet dialysate phosphate concentration. In general, phosphate clearances did not differ significantly among dialyzers, the only exception being a greater clearance with Optiflux F200NR than with the Revaclear (P = 0.002). Phosphate clearances increased significantly with increasing dialysate flow rate (P \< 0.001), with clearances at each dialysate flow rate being significantly different from those at the other flow rates. The increase in phosphate clearance with increasing dialysate flow rate was independent of the dialyzer.

###### 

Phosphate

  Dialyzer          Dialysate flow rate (mL/min)   Clearance (mL/min)[^a^](#tfn7){ref-type="table-fn"}   *K*~o~*A* (mL/min)[^b^](#tfn8){ref-type="table-fn"}   *K*~o~ (cm/min)[^b^](#tfn8){ref-type="table-fn"}
  ----------------- ------------------------------ ----------------------------------------------------- ----------------------------------------------------- --------------------------------------------------
  Optiflux F160NR   350                            168 ± 6                                               434 ± 34                                              0.028 ± 0.002
  500               178 ± 9                        450 ± 62                                              0.029 ± 0.004                                         
  800               194 ± 8                        458 ± 33                                              0.029 ± 0.002                                         
  Optiflux F200NR   350                            178 ± 8                                               504 ± 58                                              0.026 ± 0.003
  500               190 ± 6                        491 ± 29                                              0.025 ± 0.002                                         
  800               208 ± 6                        560 ± 40                                              0.029 ± 0.002                                         
  Revaclear         350                            153 ± 6                                               334 ± 24                                              0.025 ± 0.002
  500               176 ± 8                        422 ± 48                                              0.031 ± 0.004                                         
  800               186 ± 8                        415 ± 35                                              0.030 ± 0.003                                         
  Revaclear MAX     350                            167 ± 7                                               434 ± 48                                              0.026 ± 0.003
  500               179 ± 6                        435 ± 31                                              0.026 ± 0.002                                         
  800               200 ± 6                        520 ± 39                                              0.030 ± 0.002                                         

Clearances based on rate of appearance in dialysate.

Calculated using the plasma water flow rate (*Q*~PWi~).

Data are presented as mean ± SEM for *n* = 12 observations. Statistical differences are described in the text.

Calculation of *K*~o~*A* and *K*~o~ requires the blood and dialysate flow rates. Choosing the appropriate blood flow rate for phosphate is difficult because there may be some phosphate transfer between cells and plasma water as blood transits the dialyzer. Following the recommendation of Gotch and colleagues \[[@ref9]\], we used plasma water flow rate to calculate phosphate *K*~o~*A* and *K*~o~ values ([Table 3](#tab3){ref-type="table"}) in spite of recovering 11 ± 1% more phosphate in the dialysate than was lost from plasma water. The logistics of collecting samples over 45 min prevented separation of plasma and red blood cells immediately following sample collection, and as a result there was likely to have been some re-equilibration of phosphate between red blood cells and plasma water that accounted for the 11% difference. Differences in phosphate *K*~o~*A* among dialyzers were similar to those found for clearances, with the Optiflux F200NR having a significantly higher *K*~o~*A* than the Revaclear (P = 0.002). After correcting for membrane surface area, there were no differences in phosphate *K*~o~ among the four dialyzers. Neither phosphate *K*~o~*A* nor *K*~o~ differed among the three dialysate flow rates, although phosphate *K*~o~ did increase significantly with increasing dialysate velocity (*r*^2^ = 0.033, P = 0.029) ([Figure 1](#fig1){ref-type="fig"}B).

β~2~-Microglobulin {#sec13}
------------------

Clearances of β~2~-microglobulin based on plasma water flow rate are presented in [Table 4](#tab4){ref-type="table"}. Clearances of β~2~-microglobulin were significantly greater for the Revaclear and Revaclear MAX than for the Optiflux F160NR and F200NR dialyzers (P \< 0.001); however, there was no difference between the Revaclear and the Revaclear MAX or between the Optiflux F160NR and F200NR. In no case did the β~2~-microglobulin clearance depend on dialysate flow rate. For all dialyzers, clearances based on plasma water were significantly greater than clearances based on dialysate. This difference, which was independent of dialysate flow rate, reflects trapping of β~2~-microglobulin by the membrane. Overall, 46 ± 3% of β~2~-microglobulin removal by the Optiflux dialyzers was attributable to trapping at the membrane, whereas 28 ± 2% of β~2~-microglobulin removal was attributable to trapping at the membrane for the Revaclear dialyzers (P \< 0.001).

###### 

β~2~-Microglobulin

  Dialyzer          Dialysate flow rate (mL/min)   Clearance (mL/min)[^a^](#tfn9){ref-type="table-fn"}   *K*~o~*A* (mL/min)[^b^](#tfn10){ref-type="table-fn"}   *K*~o~ (cm/min)[^b^](#tfn10){ref-type="table-fn"}
  ----------------- ------------------------------ ----------------------------------------------------- ------------------------------------------------------ ---------------------------------------------------
  Optiflux F160NR   350                            54 ± 4                                                27 ± 2                                                 0.0017 ± 0.0001
  500               53 ± 5                         28 ± 2                                                0.0018 ± 0.0001                                        
  800               50 ± 6                         31 ± 5                                                0.0020 ± 0.0003                                        
  Optiflux F200NR   350                            46 ± 5                                                27 ± 2                                                 0.0014 ± 0.0001
  500               42 ± 3                         25 ± 2                                                0.0013 ± 0.0001                                        
  800               50 ± 5                         21 ± 1                                                0.0011 ± 0.0001                                        
  Revaclear         350                            75 ± 4                                                61 ± 2                                                 0.0045 ± 0.0002
  500               74 ± 5                         57 ± 2                                                0.0042 ± 0.0002                                        
  800               76 ± 5                         56 ± 3                                                0.0041 ± 0.0002                                        
  Revaclear MAX     350                            65 ± 5                                                65 ± 4                                                 0.0038 ± 0.0002
  500               80 ± 4                         62 ± 3                                                0.0037 ± 0.0002                                        
  800               73 ± 4                         64 ± 3                                                0.0038 ± 0.0002                                        

Clearances based on rate of disappearance from blood.

Calculated using the plasma water flow rate (*Q*~PWi~).

Data are presented as mean ± SEM for *n* = 12 observations. Statistical differences are described in the text.

*K*~o~*A* and *K*~o~ values for β~2~-microglobulin are presented in [Table 4](#tab4){ref-type="table"}. These values are based on dialysate-side clearances since they are not confounded by solute removal due to trapping at the membrane. β~2~-Microglobulin *K*~o~*A* and *K*~o~ were significantly greater for the two Revaclear dialyzers than for the two Optiflux dialyzers (P \< 0.001). There was no difference in *K*~o~*A* between the Revaclear and the Revaclear MAX or between the Optiflux F160NR and the Optiflux 200NR. However, after allowing for the differences in the membrane surface area, β~2~-microglobulin *K*~o~ was significantly greater for the Revaclear than for the Revaclear MAX (P = 0.001) and *K*~o~ for the Optiflux F160NR was significantly greater than for the Optiflux F200NR (P \< 0.001). Neither *K*~o~*A* nor *K*~o~ depended significantly on dialysate flow rate.

Discussion {#sec14}
==========

In their original report, Leypoldt and colleagues suggested that the increase in *K*~o~*A* associated with increasing dialysate flow rate could result from a reduced dialysate boundary layer thickness or improved flow distribution in the dialysate compartment \[[@ref2]\]. Soon thereafter, dialyzers became available with spacer yarns in the fiber bundle or fibers with undulations to improve dialysate flow distribution. Imaging studies showed that both strategies improved flow distribution and were associated with improved small molecule clearances \[[@ref5]\]. Leypoldt and colleagues confirmed that the introduction of fiber undulations in Optiflux dialyzers improved small molecule clearance *in vitro*, but found that it did not abolish the dependence of *K*~o~*A* on dialysate flow rate for urea and creatinine \[[@ref6]\]. From these observations, they concluded that the increase in *K*~o~*A* at higher dialysate flow rates results from a decrease in dialysate boundary layer thickness rather than better flow distribution in the dialysate compartment.

Our results, showing that *K*~o~*A* for urea and phosphate was statistically independent of dialysate flow rate during clinical use of dialyzers containing fibers with undulations, contrast with those of Leypoldt and colleagues \[[@ref6]\]. One possible explanation for our failure to reproduce the *in vitro* findings for dialyzers with undulating fibers in the clinical setting might be that blood-side resistance plays a greater role in determining *K*~o~*A* when fibers are perfused with blood, which is more viscous and complex than the aqueous solution used by Leypoldt *et al.* in their *in vitro* studies. This possibility is supported by observations made with the Baxter CA170 dialyzer. When the dialysate flow rate was increased from 500 to 800 mL/min, *in vitro*, Leypoldt and colleagues reported a 15% increase in urea *K*~o~*A* \[[@ref2]\], whereas we found only a 7% increase when the same flow rates were used during clinical dialysis \[[@ref3]\]. Moreover, when other dialyzers studied by Leypoldt *et al.* were used for clinical dialysis, Depner *et al.* found only a 5.5 ± 1.5% increase in urea *K*~o~*A* when the dialysate flow rate was increased from 500 to 800 mL/min \[[@ref10]\]. A second possible explanation relates to the use of different dialysis machines in the two studies. The Phoenix machine used in our study delivers a steady flow of dialysate to the dialyzer, while the dialysate flow in the Fresenius 2008E machine used by Leypoldt *et al.* is pulsatile because of the machine's balancing chamber technology. Pulsatile flow has been associated with enhanced clearances \[[@ref11]\], presumably by disrupting boundary layers or enhancing convective mass transfer through the creation of a push--pull phenomenon.

Although *K*~o~*A* for urea and phosphate was independent of dialysate flow rate, we did observe a significant increase in urea *K*~o~ and, to a lesser extent, phosphate *K*~o~ with increasing dialysate velocity ([Figure 1](#fig1){ref-type="fig"}). This observation is consistent with a reduction in the thickness of the dialysate-side boundary layer as the dialysate flow rate and, hence, the flow velocity in the dialysate compartment increases. We could only estimate the average flow velocity in the dialysate compartment based on the dialysate flow rate and the free cross-sectional area of the dialysate compartment. In practice, the dialysate-side boundary layer is a function of the local flow velocity, which is also affected by the flow distribution in the dialysate compartment. Under-perfusion of some regions of the dialysate compartment can lead to a loss of effective membrane area \[[@ref12]\]. The use of fibers with undulations has been shown to improve dialysate flow distribution compared to straight fibers \[[@ref5]\]. Moreover, Yamamoto and colleagues have shown that the design of the baffles at the inlet to the dialysate compartment also influences both dialysate flow distribution and dialyzer performance \[[@ref13; @ref14]\]. Our inability to reproduce our previous finding of a statistically significant increase in urea *K*~o~*A* with increasing dialysate flow rate \[[@ref3]\] is consistent with better dialysate flow distribution through the use of undulating fibers in the current study compared to straight fibers in our previous study, together with possible improvements in baffle design.

Taken together, our data suggest that the blood-side resistance to mass transfer is limiting for small solutes in dialyzers incorporating features to promote good flow distribution in the dialysate compartment, such as undulating fibers. Although strategies designed to increase dialysate velocity, such as increasing the fiber packing density for a given membrane surface area and fiber length, appear to have some effect on dialysate-side mass transfer resistance for small solutes, the resulting reduction in overall mass transfer resistance appears to be small in the setting of clinical dialysis where blood-side resistance is greatest.

Revaclear dialyzers provided more β~2~-microglobulin removal than Optiflux dialyzers in spite of a reduced membrane surface area. Also, trapping at the membrane contributed significantly more to removal of β~2~-microglobulin by the Optiflux membrane than by the Revaclear membrane in agreement with our previous findings \[[@ref15]\]. For all dialyzers, β~2~-microglobulin clearance was independent of dialysate flow rate, which is expected since large molecule clearances depend more on membrane surface area and permeability than on the blood and dialysate flow rates. To compare β~2~-microglobulin permeability of the membranes, *K*~o~*A* values were calculated based on the dialysate-side clearance. While β~2~-microglobulin *K*~o~*A* for the Revaclear dialyzers was significantly greater than for the Optiflux dialyzers, *K*~o~*A* did not increase with increasing membrane surface area within each dialyzer type. After correcting for membrane surface area, *K*~o~ for the dialyzer with the smaller membrane surface area was significantly greater than that for the dialyzer with the larger membrane surface area within each dialyzer type. One possible explanation for this difference is that the smaller number of fibers in the dialyzers with the smaller membrane surface area results in a higher blood compartment pressure drop at a given blood flow rate and, therefore, a greater degree of internal filtration and back-filtration that enhances large molecule removal, similar to what has been reported for decreasing fiber diameter \[[@ref16]\]. This reasoning suggests that increasing membrane surface area by increasing the length of the fibers, rather than by increasing their number, might result in a higher *K*~o~*A* for large solutes.

Overall, our data suggest that increasing dialysate flow rates in dialyzers with fiber undulations to enhance dialysate flow distribution is likely to be of limited benefit. The Michaels equation was used to predict blood water urea clearances at dialysate flow rates of 350, 500, and 800 mL/min using the urea *K*~o~*A* determined from the experimental data obtained at a dialysate flow rate of 500 mL/min. [Figure 2](#fig2){ref-type="fig"} compares this predicted clearance to the measured clearance. The data cluster around the identity line, illustrating that increasing or decreasing dialysate flow rate has essentially no effect on clearance other than the change predicted assuming a constant *K*~o~*A*. Based on a constant *K*~o~*A*, a blood flow rate of 400 mL/min and a haematocrit of 35%, the Michaels equation predicts that reducing the dialysate flow rate from 800 mL/min to 700, 600 or 500 mL/min would reduce the urea clearance by about 2, 4 and 7%, respectively. The magnitude of these changes suggests that the impact on delivered Kt/*V*~urea~ of reducing the dialysate flow rate from 800 to 600 mL/min, which would reduce concentrate consumption by 25%, is likely to be small. The comparable reductions in phosphorus clearance would be about 1, 2 and 4%, assuming clearance from plasma water, while there would be no reduction in β~2~-microglobulin clearance.

![Predicted urea clearance versus measured urea clearance. Urea clearance predicted using the Michaels equation and a constant *K*~o~*A* (derived from experimental data for *Q*~D~ = 500 mL/min) did not differ from the measured clearances at dialysate flow rates of 350 and 800 mL/min. Data are presented as mean ± SEM for *n* = 12. The solid line is the line of identity.](gfq326fig2){#fig2}

In summary, increasing the dialysate flow rate from 500 to 800 mL/min had only a modest impact on dialyzer performance, limited to the theoretical increase predicted by the Michaels equation for a constant *K*~o~*A*. This finding suggests that increasing the dialysate flow rate beyond 500--600 mL/min may provide only a marginal benefit in terms of delivered Kt/*V*, although this possibility needs to be confirmed in a randomized clinical trial. The data also suggest that increasing membrane surface area may not necessarily increase the removal of large solutes if the increase in surface area is achieved by increasing the number of fibers.
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